Date published: 2025-11-22

1-800-457-3801

SCBT Portrait Logo
Seach Input

SHIP-1 Activators

Common SHIP-1 Activators include, but are not limited to Perifosine CAS 157716-52-4, NSC 87877 CAS 56990-57-9, Sorafenib CAS 284461-73-0, Sunitinib Malate CAS 341031-54-7 and Dasatinib CAS 302962-49-8.

SHIP-1, or SH2-containing inositol 5'-phosphatase 1, is an intracellular enzyme that plays a critical role in the modulation of phosphoinositide signaling within cells. Phosphoinositides are phospholipids that reside in cell membranes and serve as essential secondary messengers in various cellular processes. SHIP-1 specifically acts on phosphatidylinositol 3,4,5-trisphosphate (PI(3,4,5)P3), converting it to phosphatidylinositol 3,4-bisphosphate (PI(3,4)P2). This enzymatic conversion has significant implications in the regulation of numerous signaling pathways, especially those associated with cellular growth, survival, and differentiation. By modulating the levels of specific phosphoinositides, SHIP-1 serves as a negative regulator, ensuring that cellular signaling remains balanced and controlled.

Activators of SHIP-1 are molecules or compounds that enhance the activity or expression of the SHIP-1 enzyme. These activators can function by directly promoting the enzymatic activity of SHIP-1 or by bolstering its expression at the transcriptional or translational levels. The presence of SHIP-1 activators can lead to a shift in the balance of phosphoinositides within cells, thereby influencing the downstream signaling cascades regulated by these lipids. The mechanisms through which different SHIP-1 activators exert their effects can vary based on their chemical structure and the specific cellular context. Deepening our understanding of SHIP-1 activators offers a window into the intricate and nuanced world of phosphoinositide signaling. As science continues to unravel the myriad of cellular communication pathways, the role of SHIP-1 and its activators emerges as a testament to the complexity and precision of intracellular signaling mechanisms.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Perifosine

157716-52-4sc-364571
sc-364571A
5 mg
10 mg
$184.00
$321.00
1
(2)

Akt inhibitor that might indirectly modulate SHIP-1 activity or expression.

NSC 87877

56990-57-9sc-204139
50 mg
$134.00
12
(1)

Inhibitor of SHP-1 and SHP-2. While not a direct SHIP-1 activator, it's related to the same pathway and may have indirect effects.

Sorafenib

284461-73-0sc-220125
sc-220125A
sc-220125B
5 mg
50 mg
500 mg
$56.00
$260.00
$416.00
129
(3)

A kinase inhibitor that may indirectly influence SHIP-1 activity via modulation of related pathways.

Sunitinib Malate

341031-54-7sc-220177
sc-220177A
sc-220177B
10 mg
100 mg
3 g
$193.00
$510.00
$1072.00
4
(1)

Multi-targeted receptor tyrosine kinase inhibitor that might influence SHIP-1 activity indirectly.

Dasatinib

302962-49-8sc-358114
sc-358114A
25 mg
1 g
$47.00
$145.00
51
(1)

Inhibits multiple tyrosine kinases and might have an indirect effect on SHIP-1 activity.

BKM120

944396-07-0sc-364437
sc-364437A
sc-364437B
sc-364437C
5 mg
10 mg
25 mg
50 mg
$173.00
$230.00
$275.00
$332.00
9
(0)

PI3K inhibitor that may indirectly affect SHIP-1 activity and its regulation.

LY 294002

154447-36-6sc-201426
sc-201426A
5 mg
25 mg
$121.00
$392.00
148
(1)

PI3K inhibitor that can indirectly influence the pathways where SHIP-1 is involved.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$66.00
$219.00
$417.00
97
(3)

Another PI3K inhibitor that can modulate the PI3K/Akt pathway and potentially influence SHIP-1.

CAL-101

870281-82-6sc-364453
10 mg
$189.00
4
(1)

PI3Kδ inhibitor used for certain cancers; might indirectly modulate SHIP-1 activity.

IPI 145

1201438-56-3sc-488318
5 mg
$311.00
(0)

PI3Kδ and PI3Kγ inhibitor, potentially affecting SHIP-1 indirectly.